首页> 美国卫生研究院文献>Archives of Disease in Childhood >Mutation analysis in 46 British and Irish patients withGauchers disease
【2h】

Mutation analysis in 46 British and Irish patients withGauchers disease

机译:46例英国和爱尔兰患者的突变分析。高雪氏病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Accepted 18 March 1997
DNA from 46 unrelated patients with Gaucher's disease was analysed for 10 known mutations: 84GG(c84 G 85ins), N370S (c1226G), L444P (c1448C), R463C (c1504T), R496H (c1604A), IVS2+1, D409H (c1342C), RecNciI (c1448C-1498C), RecTL (c1342C-1498C), and c1263del (c1264-1318del). Fifty four mutations (90%) were identified in 30 patients with type I disease. These included a previously undescribed recombinant mutation RecA456P (c1448C-1484C). Thirteen (54%) of 24 type II alleles were identified, including one new point mutation N462K (c1503G) and one new 55bp deletion also incorporating the RecTL mutations c1263del+RecTL (c1264del-1498C). All four type III patients were homozygous for the L444P point mutation. Generally, patients with one copy of the N370S mutation had mild adult onset disease, regardless of the nature of their second mutation. Three exceptions had childhood onset disease and genotypes N370S/R463C, N370S/RecA456P, and N370S/?. The L444P/L444P genotype was thought to be associated with neurological disease. Two type I patients with this genotype who exhibited no central nervous system disease were identified, however. The R463C and c1263del mutations were found to be present at a higher frequency than reported in other populations and they should be included in any mutation screen of this population. The recombinant mutations RecA456P and c1263del+RecTL have not been previously described and are the fourth and fifth recombinant mutationsidentified in the glucocerebrosidase gene.

机译:1997年3月18日被接受的
DNA进行了分析,分析了来自46位无关的高雪氏病患者的10种已知突变:84GG(c84 G 85ins),N370S(c1226G),L444P(c1448C),R463C(c1504T),R496H(c1604A), IVS2 + 1,D409H(c1342C),RecNciI(c1448C-1498C),RecTL(c1342C-1498C)和c1263del(c1264-1318del)。在30例I型疾病患者中鉴定出54个突变(90%)。这些包括先前未描述的重组突变RecA456P(c1448C-1484C)。鉴定出24个II型等位基因中的13个(54%),包括一个新的点突变N462K(c1503G)和一个新的55bp缺失,其中还整合了RecTL突变c1263del + RecTL(c1264del-1498C)。所有四位III型患者L444P点突变均为纯合子。通常,具有N370S突变一拷贝的患者患有轻度的成人发病,而不论其第二突变的性质如何。三个例外是儿童期发病,其基因型分别为N370S / R463C,N370S / RecA456P和N370S /α。 L444P / L444P基因型被认为与神经系统疾病有关。但是,确定了两名没有这种基因型的I型患者,但没有中枢神经系统疾病。发现R463C和c1263del突变的发生频率高于其他人群中报告的频率,因此应将其包括在该人群的任何突变筛选中。重组突变RecA456P和c1263del + RecTL以前没有描述过,它们是第四和第五个重组突变在葡萄糖脑苷脂酶基因中鉴定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号